|
Troynoxa is a blood thinner, also called anti-coagulant, which
prevents the formation of blood clots. Troynoxa is used to
prevent blood clots that are sometimes called Deep Vein Thrombosis
(DVT), which can lead to blood clots in the lungs. A DVT can
occur after certain types of surgery or in people who are
bed-ridden due to a prolonged illness.
Troynoxa
is also used to prevent blood vessel complications in people
with certain types of angina (chest pain) or heart attacks
called non-Q-wave myocardial infarction or ST-segment elevation
myocardial infarction.
|
|
 |
|
Indication
& Usage: Troynoxa is a low molecular weight heparin
[LMWH] indicated for:
- Prophylaxis
of deep vein thrombosis (DVT) in abdominal surgery, hip
replacement surgery, knee replacement surgery or medical
patients with severely restricted mobility during acute
illness
- Inpatient
treatment for acute DVT with or without pulmonary embolism
-
Outpatient treatment for acute DVT without pulmonary embolism
-
Prophylaxis of ischemic complications of unstable angina
and non-Q-wave myocardial infarction [MI]
-
Treatment for acute ST-segment elevation myocardial infarction
[STEMI] managed medically or with subsequent percutaneous
coronary intervention [PCI]
Dosage
forms & Strengths: 100 mg/ml concentration.
-
Graduated pre-filled syringes: 40 mg/0.4 ml, 60 mg/0.6 ml
|
